Cantor Fitzgerald Weighs in on APLS FY2026 Earnings
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for Apellis Pharmaceuticals in a research note issued on Monday, June 9th. Cantor Fitzgerald analyst S. Seedhouse expects that the company will post earnings per share of ($0.80) for the year. Cantor Fitzgerald has a “Overweight” rating and […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for Apellis Pharmaceuticals in a research note issued on Monday, June 9th. Cantor Fitzgerald analyst S. Seedhouse expects that the company will post earnings per share of ($0.80) for the year. Cantor Fitzgerald has a “Overweight” rating and […]
